+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Company Analysis: United Therapeutics

The publisher explores United Therapeutics’ prescription pharmaceutical performance and outlook over 2019-29.

Snapshot
  • Overview - United Therapeutics’ prescription pharmaceutical business is heavily impacted by generic competition.
  • Key themes - [1] Generic competition is causing a severe impact on United Therapeutics’ pharmaceutical business, with Adcirca and Remodulin impacted in 2019 [2] Recent settlements with Watson and Actavis regarding generic versions of Tyvaso and Orenitram will keep generics at bay until 2026 and 2027 [3] Future growth depends on ralinepag, which United Therapeutics in-licensed from Arena for $1.2bn, with $800m upfront.
Model updates (4 November 2020)
  • Remodulin forecast adjusted lower in Europe and Rest of World due to lower sales
  • Tyvaso forecast adjusted higher due to stronger sales
  • Orenitram forecast adjusted higher due to stronger sales.
Model updates (29 July 2020)
  • Remodulin forecast adjusted lower due to lower international sales
  • Tyvaso forecast adjusted higher due to sales strength in the US
  • Orenitram forecast adjusted higher due to FREEDOM-EV label update.
Model updates (29 April 2020)
  • No changes to forecasts.
Model updates (26 February 2020)
  • Tyvaso forecast adjusted higher due to results from Phase III INCREASE trial in patients with PH-ILD.
Note: Product cover images may vary from those shown
Company Background
  • Company Overview
  • Key Metrics
  • SWOT Analysis
  • Key Drug & Company Information
  • Company Comparison
Recent Earnings Review
  • Earnings Overview
Company Forecast
  • Prescription Pharmaceuticals Sales Outlook
  • Branded Drug Outlook
  • Launch Profile Outlook
  • Therapy Area Outlook
  • Regional Sales Outlook
  • Lifecycle Analysis
Company Profile
  • Marketed & Pipeline Drugs
  • Upcoming Catalysts
  • Recent Insights
Clinical Trial Overview
  • Clinical Trial Snapshot
  • Clinical Trials by Country
  • Clinical Trials by Status and Phase
  • Clinical Trials by Drug
Note: Product cover images may vary from those shown
Adroll
adroll